HealthDay News — The prevalence of diabetes was 15.8 percent among U.S. adults during August 2021 to August 2023, according to a November data brief published by the National Center for Health ...

Patients being treated for neovascular age-related macular degeneration (nAMD) appear to have less likelihood of submacular hemorrhage (SMH) when their most recent biologic agent was faricimab, ...

Patients with stage 4 retinopathy of prematurity (ROP) experience long-term benefits from vitrectomy, according to a study published in the British Journal of Ophthalmology.

Work-related stress is associated with lower odds of having average and optimal cardiovascular health (CVH), according to a study published online Nov. 6 in the ...

Tocilizumab treatments in patients with noninfectious uveitis demonstrated high rates of success at 1 year follow ups.

Lack of health insurance coverage accounts for a considerable proportion of racial and ethnic disparities in advanced-stage diagnoses of cancer.

Graves disease and cancer were associated with each other, as Graves disease diagnosis was linked to increased risks for ovarian and prostate cancers.

Institutional leaders consider policies about late-career physicians (LCPs; physicians working beyond age 65 to 75 years) to be successful. HealthDay News — Institutional leaders consider policies ...

Conjunctival breach and a late onset are common in cases of endophthalmitis associated with implantation of an anti-VEGF delivery device.

Treatment-limiting decisions occurred in nearly half of patients with severe TBI and the prevalence of such decisions has increased over time.

In a research letter published online Nov. 5 in the Annals of Internal Medicine, nationally representative measures of patient travel patterns are presented.

New data suggest that the United States launches the most new cancer drugs of any other country and is most likely to launch cancer drugs first.